Treatment of tuberculosis
Jean-Pierre Zellweger
Abstract
Jean-Pierre Zellweger
Abstract
Tuberculosis is still one of the main infectious diseases affecting mankind and is poorly controlled, despite the availability of cheap and effective drugs for the past 40–50 years. There are three basic principles of treatment against tuberculosis defined by the WHO and International Union Against Tuberculosis and Lung Disease (IUATLD). First is the use of potent bactericidal drugs in combination, to render the patients noninfective as rapidly as possible and prevent the transmission to other patients. Second, prolonged treatment eradicates even the dormant bacteria and prevents relapse. Third, regular treatment with correct doses is given in order to prevent the development of drug resistance. Most cases of tuberculosis can still be cured by a correct combination of isoniazid, rifampicin, pyrazinamide and ethambutol administered for 2 months, followed by isoniazid and rifampicin for 4 months. Antituberculous drugs are associated with adverse events, particularly in patients with comorbidities such as HI...
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Tuberculosis is still one of the main infectious diseases affecting mankind and is poorly controlled, despite the availability of cheap and effective drugs for the past 40–50 years. There are three basic principles of treatment against tuberculosis defined by the WHO and International Union Against Tuberculosis and Lung Disease (IUATLD). First is the use of potent bactericidal drugs in combination, to render the patients noninfective as rapidly as possible and prevent the transmission to other patients. Second, prolonged treatment eradicates even the dormant bacteria and prevents relapse. Third, regular treatment with correct doses is given in order to prevent the development of drug resistance. Most cases of tuberculosis can still be cured by a correct combination of isoniazid, rifampicin, pyrazinamide and ethambutol administered for 2 months, followed by isoniazid and rifampicin for 4 months. Antituberculous drugs are associated with adverse events, particularly in patients with comorbidities such as HI...
Key concepts: Pyrazinamide, Ethambutol, Rifampicin, Tuberculosis, Medicine, Isoniazid, Adverse effect, Drug